Journals / Journal of Contemporary Medicine / 2025 / Cilt: 15 Sayı: 5

Single center experience in neuroblastoma, surgical results and complications

Nöroblastomda tek merkez deneyimi, cerrahi sonuçlar ve komplikasyonlar

Pages
238–244
Publication Date
2025-09-30
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It may be possible to avoid serious complications by customizing the surgery.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Abstract Background/Aims: Neuroblastoma (NB) is an embryonal neuroendocrine tumor of the peripheral nervous system.
📊
Key Findings & Data:It is the most common extracranial solid tumor of childhood and the most common in the first year of life.It has a variable course ranging from a benign course to a fatal disease Methods: Forty patients under the age of 18 who underwent surgical resection in our center due to neuroblastoma between January 2012 and December 2021 were included in to the study.
💡
Conclusion & Impact:It may be possible to avoid serious complications by customizing the surgery.
🔬Design:Text.Serial.Journal
📍Scope:2012 Verileri
⚙️Variables:nöroblastom · cerrahi · klinik davranış

Abstract

Abstract Background/Aims: Neuroblastoma (NB) is an embryonal neuroendocrine tumor of the peripheral nervous system. It is the most common extracranial solid tumor of childhood and the most common in the first year of life.It has a variable course ranging from a benign course to a fatal disease Methods: Forty patients under the age of 18 who underwent surgical resection in our center due to neuroblastoma between January 2012 and December 2021 were included in to the study. Demographic data of the patients, preoperative cross-sectional and functional imaging, surgical procedures, surgical complications and pathological staging were analyzed retrospectively. Results: In this retrospective study, 48 patients were analyzed. Of 48 patients 52.5% were male and 47.5% were female. palpable abdominal mass detected in 82.5% of the patients. 0 patients were neuroblastoma, 10 patients were ganglioneuroblastoma, and 8 patients were ganglioneuromas. Eight patients with ganglioneuroma were excluded from the study. Analysis was performed among 40 patients. Conclusions: NB is heterogeneous in clinical behavior. It is treated by the pediatric surgeon with minimal complications, taking into account the stage of the disease, the age of the patient, and risk factors. Since the tumor originates from the sympathetic nervous system and invades surrounding large vessels and surrounding tissues, aggressive chemotherapy and local regional radiotherapy may be required after surgery. It may be possible to avoid serious complications by customizing the surgery.

Özet

Özet Arka Plan/Amaçlar: Nöroblastom (NB), periferik sinir sisteminin embriyonal nöroendokrin tümörüdür. Çocukluk çağının en sık görülen ekstrakraniyal solid tümörüdür ve yaşamın ilk yılında en sık görülür. İyi huylu bir seyirden ölümcül bir hastalığa kadar değişen değişken bir seyir gösterir Yöntemler: Ocak 2012 ile Aralık 2021 arasında merkezimizde nöroblastom nedeniyle cerrahi rezeksiyon geçiren 18 yaş altı kırk hasta çalışmaya dahil edildi. Hastaların demografik verileri, ameliyat öncesi kesitsel ve fonksiyonel görüntüleme, cerrahi prosedürler, cerrahi komplikasyonlar ve patolojik evreleme retrospektif olarak analiz edildi. Sonuçlar: Bu retrospektif çalışmada 48 hasta analiz edildi. 48 hastanın %52,5'i erkek ve %47,5'i kadındı. Hastaların %82,5'inde elle muayene edilebilen abdominal kitle tespit edildi. 0 hasta nöroblastoma, 10 hasta ganglionöroblastoma ve 8 hasta ganglionöroma idi. Ganglionöroma olan sekiz hasta çalışmadan hariç tutuldu. Analiz 40 hasta arasında yapıldı. Sonuçlar: NB klinik davranışta heterojendir. Hastalığın evresi, hastanın yaşı ve risk faktörleri dikkate alınarak, pediatrik cerrah tarafından minimal komplikasyonlarla tedavi edilir. Tümör sempatik sinir sisteminden kaynaklandığı ve çevredeki büyük damarları ve çevre dokuları istila ettiği için, ameliyattan sonra agresif kemoterapi ve lokal bölgesel radyoterapi gerekebilir. Ameliyatı kişiselleştirerek ciddi komplikasyonlardan kaçınmak mümkün olabilir.

🔖

Cite This Article

Cesur, İ. B., Özçelik, Z., Ekberli, G., Yağcı-küpeli, B. (2025). Single center experience in neuroblastoma, surgical results and complications. Journal of Contemporary Medicine, Cilt: 15 Sayı: 5, 238–244. https://doi.org/10.16899/jcm.1699324

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. London WB, Castleberry RP, Matthay KK, Look AT, Seeger RC, Shimada H, et al. Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children’s Oncology Group. J Clin Oncol. 2005
  2. Maris JM. Recent advances in neuroblastoma. N Engl J Med. 2010
  3. Li J, Thompson TD, Miller JW, et al. Cancer incidence among children and adolescents in the United States, 2001-2003. Paediatrics. 2008
  4. Vo KT, et al. Clinical, biologic, and prognostic differences on the basis of primary tumour site in neuroblastoma: a report from the international neuroblastoma risk group Project. J Clin Oncol. 2014
  5. Brodeur GM, Maris JM, Yamashiro DJ, et al. Neuroblastoma. In: Pizzo PA, Poplack DG, eds. Principles and Practice of Paediatric Oncology. 7th ed. Lippincott Williams & Wilkins
  6. Cohn SL, Pearson AD, London WB, et al. The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report. J Clin Oncol. 2009
  7. Morgenstem DA, et al. Prognostic significance of pattern and burden of metastatic disease in patients with stage 4 neuroblastoma: A Study from the International Neuroblastoma Risk Group database. Eur J Cancer. 2016
  8. Wen Z, Zhang L, Zhuang H. Roles of PET/Computed Tomography in the Evaluation of Neuroblastoma. PET Clin. 2020
  9. Monclair T, Brodeur GM, Ambros PF, et al. The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report. J Clin Oncol. 2009
  10. D'Angio GJ, Evans AE, Koop CE. International Neuroblastoma Staging System (INSS): a new staging system for neuroblastoma. J Clin Oncol. 1988
  11. Chung C, Boterberg T, Lucas J, Panoff J, Valteau-Couanet D, Bagatell R. Neuroblastoma. Pediatr Blood Cancer. 2021
  12. e28473. 12.Croteau N, Nuchtern J, LaQuaglia MP. Management of Neuroblastoma in Paediatric Patients. Surg Oncol Clin N Am. 2021
  13. Swift CC, Eklund MJ, Kraveka K, Basu Emi Roberts S, Hammond E, et al. Management and Treatment of Neuroblastoma. Radiographics. 2018
  14. Rubie H, et al. Survival and prognosis in localised and metastatic neuroblastoma treated according to the European Neuroblastoma Study Group (ENGS) guidelines. Cancer Res. 2010
  15. 70(24 Suppl):Abstract 4656. 15.Yao W, Li K, Dong KR, Zheng S, Xiaom XM. Long-term prognosis of low-risk neuroblastoma treated by surgery alone: an experience from a single institution of China. World